secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2022-09-30T23:59:59+00:00
Accession:  0001213900-22-060675
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma (CPHI) gets NYSE American deficiency notice; avg price below $0.20, must cure by March 2023
--------------------------------------------------------------------------------

- Average stock price below $0.20 over 30 days as of Sept 22, 2022 triggers continued listing noncompliance.
- NYSE American requires reverse stock split or sustained price improvement by March 26, 2023 to maintain listing.
- Company also subject to prior stockholders' equity noncompliance letter from June 2022.
- Stock continues trading on NYSE American while company pursues compliance measures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022060675/0001213900-22-060675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022060675/ea166544-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-060675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer